Depomed reported $30.6M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aerie Pharmaceuticals AERI:US $ 29.57M 6.52M
Aurora Cannabis Inc ACB:CN -52930000 16.56M
Cara Therapeutics CARA:US 23M 20.29M
Daiichi Sankyo 4568:JP Y 205519M 60424M
Depomed DEPO:US $ 30.6M 2.14M
Johnson & Johnson JNJ:US $ 16101M 273M
Knight Therapeutics Inc GUD:CN C$ 38.3M 5.82M
Merk MRK:US $ 10895M 328M
Nektar Therapeutics NKTR:US $ 16.47M 3.04M
Pfizer PFE:US $ 19071M 3420M
Teva Pharmaceutical TEVA:IT 1.83B 26M